Peptide Numbness: Labs, Causes, and Next Steps
Numbness during peptide therapy (GLP-1s, BPC-157, TB-500, semaglutide, tirzepatide) has identifiable causes. Learn which labs to order, what the findings mean, and when to escalate care.
4 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 4 of 4 clinical reviews.
Numbness during peptide therapy (GLP-1s, BPC-157, TB-500, semaglutide, tirzepatide) has identifiable causes. Learn which labs to order, what the findings mean, and when to escalate care.
Peptide therapy can cause numbness and tingling through several mechanisms. Learn the differential diagnosis, when to seek help, and how clinicians evaluate peptide-related paresthesias.
Numbness or tingling during peptide therapy may signal a benign injection-site reaction or a serious neuropathy. Learn causes, red flags, diagnostic steps, and when to seek medical evaluation.
Evidence-led triage for numbness during peptide or GLP-1 use, separating emergencies, altered skin sensation, neuropathy, and medication causes.